We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Epizyme Achieves $4 Million Pre-Clinical Milestone Payment in Eisai Strategic Partnership

News   Jan 13, 2012

 
Epizyme Achieves $4 Million Pre-Clinical Milestone Payment in Eisai Strategic Partnership
 
 
Advertisement
 

RELATED ARTICLES

Metabolomics Meets Genomics To Improve Patient Diagnosis

News

Researchers from Baylor College of Medicine have integrated whole-exome sequencing and targeted metabolomics to analyze the data of a group of 170 patients. They were pleased to find that the metabolomics data informed 44 percent of the cases.

READ MORE

Common Genetic Variant Identified As Frequent Cause of Deafness

News

A common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals research.

READ MORE

Light-activated Nanoparticles Inhibit Tumor Growth

News

A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to new research conducted at Penn State University.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE